Biopharmaceutical company Biocon is planning to submit a request for approval of generic copies of the blockbuster ...

The biosimilars market is estimated to reach USD 66.9 billion by 2028 from USD 29.4 billion in 2023, at a CAGR of 17.8% ...

Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years, a top executive told Reuters ...

By Rishika Sadam HYDERABAD (Reuters) -Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years, a top executive told Reuters, ...

State Bank of India (SBI), the largest lender in the country, has launched a share sale to institutional investors to raise ...

Indian market closed with a positive bias, as BSE Sensex and Nifty50 saw gains, led by auto, FMCG, realty, and IT sectors. Biocon, RBL Bank, and HDFC AMC hit fresh 52-week highs. Analysts suggest ...

The global healthcare landscape is in a constant state of evolution, driven by technological breakthroughs, demographic ...

The global drug discovery services market is projected to grow at a CAGR of 15% from 2025 to 2030. This growth is driven by the increasing demand for outsourced drug discovery activities, advancements ...

HDFC Asset Management Company reported a 24% on-year jump in net profit to Rs 748 crore for the first quarter of the financial year 2026.

The Board of Directors of Oriental Hotels Limited, at its meeting held today have approved the financial results of the ...

The Board of Directors of ICICI Prudential Life Insurance Company Limited, at its meeting held today have approved the ...

Indian benchmark indices Sensex and Nifty closed marginally higher on Wednesday, recouping early losses as gains in PSU banks ...